BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33402167)

  • 1. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
    Zhang D; Li S; Hou L; Jing L; Ruan Z; Peng B; Zhang X; Hong JS; Zhao J; Wang Q
    J Neuroinflammation; 2021 Jan; 18(1):4. PubMed ID: 33402167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson's Disease Mouse Model.
    Jing L; Hou L; Zhang D; Li S; Ruan Z; Zhang X; Hong JS; Wang Q
    J Inflamm Res; 2021; 14():1341-1356. PubMed ID: 33859489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial gp91phox-mediated neuroinflammation and ferroptosis contributes to learning and memory deficits in rotenone-treated mice.
    Tian L; Tang P; Liu J; Liu Y; Hou L; Zhao J; Wang Q
    Free Radic Biol Med; 2024 Aug; 220():56-66. PubMed ID: 38697489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.
    Ding W; Lin H; Hong X; Ji D; Wu F
    Toxicology; 2020 Apr; 436():152437. PubMed ID: 32169474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
    Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.
    Hou L; Qu X; Qiu X; Huang R; Zhao X; Wang Q
    J Neuroinflammation; 2020 May; 17(1):148. PubMed ID: 32375810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rotenone impairs learning and memory in mice through microglia-mediated blood brain barrier disruption and neuronal apoptosis.
    Guo Z; Ruan Z; Zhang D; Liu X; Hou L; Wang Q
    Chemosphere; 2022 Mar; 291(Pt 2):132982. PubMed ID: 34822863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor 3-mediated neurotoxic glial activation contributes to rotenone-induced cognitive decline in mice.
    Wang Q; Ruan Z; Jing L; Guo Z; Zhang X; Liu J; Tian L; Sun W; Song S; Hong JS; Shih YI; Hou L; Wang Q
    Ecotoxicol Environ Saf; 2023 Nov; 266():115550. PubMed ID: 37832486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.
    Hou L; Liu J; Sun F; Huang R; Chang R; Ruan Z; Wang Y; Zhao J; Wang Q
    J Neuroinflammation; 2023 Feb; 20(1):42. PubMed ID: 36804009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
    Li Q; Shen C; Liu Z; Ma Y; Wang J; Dong H; Zhang X; Wang Z; Yu M; Ci L; Sun R; Shen R; Fei J; Huang F
    Cell Prolif; 2021 Aug; 54(8):e13094. PubMed ID: 34312932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson's disease model through inhibition of microglial activation.
    Wang K; Shi Y; Liu W; Liu S; Sun MZ
    Neurotoxicology; 2021 Mar; 83():129-136. PubMed ID: 33450328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    De Miranda BR; Rocha EM; Bai Q; El Ayadi A; Hinkle D; Burton EA; Timothy Greenamyre J
    Neurobiol Dis; 2018 Jul; 115():101-114. PubMed ID: 29649621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.
    Rabaneda-Lombarte N; Serratosa J; Bové J; Vila M; Saura J; Solà C
    J Neuroinflammation; 2021 Apr; 18(1):88. PubMed ID: 33823877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-N-(2-hydroxyethyl)-2-oxoacetamide (CDMPO) has anti-inflammatory properties in microglial cells and prevents neuronal and behavioral deficits in MPTP mouse model of Parkinson's disease.
    Kim B; Park JY; Cho DY; Ko HM; Yoon SH; Choi DK
    Neuropharmacology; 2020 Apr; 166():107928. PubMed ID: 31887307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.
    Hou L; Sun F; Huang R; Sun W; Zhang D; Wang Q
    Redox Biol; 2019 Apr; 22():101134. PubMed ID: 30798073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects.
    Mansour RM; Ahmed MAE; El-Sahar AE; El Sayed NS
    Toxicol Appl Pharmacol; 2018 Nov; 358():76-85. PubMed ID: 30222980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
    Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
    J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.
    Rocha SM; Bantle CM; Aboellail T; Chatterjee D; Smeyne RJ; Tjalkens RB
    Neurobiol Dis; 2022 Jun; 167():105685. PubMed ID: 35257879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
    Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
    Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.